Front Row Advisors’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
Other funds holding CHE
Front Row Advisors's CHE Position: Q3 2024 in Review
Front Row Advisors sold out of Chemed (CHE) in Q3 2024, closing a stake of 9 shares — an estimated $4.88K sold.
Front Row Advisors first reported a position in CHE in Q4 2017 and held it in 26 quarters. The position peaked at $10K in Q4 2020. 528 funds tracked by Wall St. Rank hold CHE as of Q3 2024.
- Front Row Advisors reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
- Front Row Advisors sold 9 Chemed shares in Q3 2024, an estimated $4.88K.
- Front Row Advisors first reported a position in Chemed in Q4 2017 and held it in 26 quarters.
- Front Row Advisors's Chemed position peaked at $10K in Q4 2020.
- 528 funds tracked by Wall St. Rank held Chemed as of Q3 2024.
Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.